Multiple Sclerosis and Microbiome
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388971%3A_____%2F22%3A00556542" target="_blank" >RIV/61388971:_____/22:00556542 - isvavai.cz</a>
Alternative codes found
RIV/00064165:_____/22:10444023 RIV/00216208:11110/22:10444023
Result on the web
<a href="https://www.mdpi.com/2218-273X/12/3/433" target="_blank" >https://www.mdpi.com/2218-273X/12/3/433</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3390/biom12030433" target="_blank" >10.3390/biom12030433</a>
Alternative languages
Result language
angličtina
Original language name
Multiple Sclerosis and Microbiome
Original language description
The composition of microbiota and the gut-brain axis is increasingly considered a factor in the development of various pathological conditions. The etiology of multiple sclerosis (MS), a chronic autoimmune disease affecting the CNS, is complex and interactions within the gut-brain axis may be relevant in the development and the course of MS. In this article, we focus on the relationship between gut microbiota and the pathophysiology of MS. We review the contribution of germ-free mouse studies to our understanding of MS pathology and its implications for treatment strategies to modulate the microbiome in MS. This summary highlights the need for a better understanding of the role of the microbiota in patients' responses to disease-modifying drugs in MS and disease activity overall.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
10608 - Biochemistry and molecular biology
Result continuities
Project
<a href="/en/project/NU20-04-00077" target="_blank" >NU20-04-00077: Microbiome, its role in effectiveness of immunomodulatory therapy and pathogenesis of MS.</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Biomolecules
ISSN
2218-273X
e-ISSN
2218-273X
Volume of the periodical
12
Issue of the periodical within the volume
3
Country of publishing house
CH - SWITZERLAND
Number of pages
10
Pages from-to
87
UT code for WoS article
000776025800001
EID of the result in the Scopus database
—